CLINICAL_TRIALS trial_result · 2023-06-28

Clinical Trial Update: Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years [Phase 3]

Phase 3 trial evaluating ELX/TEZ/IVA in children aged 2 through 5 years with cystic fibrosis has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2023-06-28